Loading…

IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors

Co-administration of IL-12 with vaccine immunogens has proven to be an effective strategy for eliciting potent Th1-biased immunity. Unfortunately, the use of IL-12 as a vaccine component has been limited because it is unstable at ambient temperatures, expensive to produce, and toxic when administere...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2006-02, Vol.24 (9), p.1451-1461
Main Authors: Klas, Sheri D., Lavine, Christy L., Whitt, Michael A., Miller, Mark A.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Co-administration of IL-12 with vaccine immunogens has proven to be an effective strategy for eliciting potent Th1-biased immunity. Unfortunately, the use of IL-12 as a vaccine component has been limited because it is unstable at ambient temperatures, expensive to produce, and toxic when administered at excessive dosages. Using reverse genetics, we created a recombinant replication-restricted vesicular stomatitis virus that expresses large quantities of an IL-12 fusion protein (VSVΔG-IL12F), but can only establish a single round of infection because the genome does not encode the viral glycoprotein (G protein) that is required for viral entry into host cells. Here, we report that immunization of mice with a poorly immunogenic listerial antigen preparation (LMAg) in combination with VSVΔG-IL12F elicits potent T cell- and B cell-mediated responses that confer protective listerial immunity.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2005.05.046